An investor group including former CEOs of Celgene Corp. (NASDAQ:CELG) and Medtronic plc (NYSE:MDT) has acquired immuno-oncology company NexImmune Inc. (Gaithersburg, Md.) for an undisclosed amount.
The group includes
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury